Business of Cannabis recently sat down with Releaf’s Chief Operating Officer, Graham Woodward, a trained psychiatric nurse and former clinical director and CQC Specialist Advisor, to discuss the impact of the lack of access to training how clinics such as Releaf are working to change it.Â
Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, along with stories and testimonies from dozens of patients who say they are thriving thanks to cannabis-based medicines.Â
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC).
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.
Script Assist, a digital platform for medical cannabis prescribing, is excited to announce that CB1 Medical will be the first
Allowing GPs to prescribe medical cannabis can drive down NHS waiting lists and reduce crime, according to a new report
LAST week a flurry of positive announcements from across the UK’s medical cannabis industry were unveiled in signs the industry
NEW UK government data suggest that the number of NHS prescriptions for ‘licenced’ cannabis-based medicines could rise significantly this year.Â
THE UK’s Health Research Authority (HRA) has approved the country’s first clinical study using cannabis flower for the treatment of
THE Government has eventually responded to a report into the progress of the UK’s medical cannabis prescribing regime – over
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
